Atlas Trials

Patient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in Belgium

Clinical trial NCT04221802 · COMPLETED

Trial details

NCT number
NCT04221802
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Severe Asthma
Start date
2019-12-23
Primary completion
2024-05-13
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.